Acquired drug resistance is one of the most important problems in cancer ch
emotherapy. One of the proposed mechanisms for these phenomena is the seque
stration of alkylating agents by metallothionein in vivo. This research sho
ws that metallothionein can covalently sequester phosphoramide mustard, the
active form of cyclophosphamide in vitro. On-line electrospray mass spectr
ometry reveals that it is phosphoramide, not nornitrogen mustard that alkyl
ates metallothionein, although the metallothionein/nornitrogen mustard addu
ct was isolated as the major adduct. Tandem mass spectrometric experiments
were performed on an isolated drug-modified tryptic peptide. The alkylation
occurred predominantly at Cys48 of metallothionein. These results provide
further evidence that overexpression of metallothionein can detoxify the ac
tive form of the drugs.